BIOMAT Database Logo BIOMAT Database Logo

[Effect of a methylhydrazine derivative, Ro 4-6467, in Hodgkin's disease, in other malignant lymphomas and in leukemias]. 1965

Y Kenis, and J Werli, and J Hildebrand, and H J Tagnon

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D008223 Lymphoma A general term for various neoplastic diseases of the lymphoid tissue. Germinoblastoma,Lymphoma, Malignant,Reticulolymphosarcoma,Sarcoma, Germinoblastic,Germinoblastic Sarcoma,Germinoblastic Sarcomas,Germinoblastomas,Lymphomas,Lymphomas, Malignant,Malignant Lymphoma,Malignant Lymphomas,Reticulolymphosarcomas,Sarcomas, Germinoblastic
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006689 Hodgkin Disease A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen. Granuloma, Hodgkin,Granuloma, Malignant,Hodgkin Lymphoma,Lymphogranuloma, Malignant,Granuloma, Hodgkin's,Granuloma, Hodgkins,Hodgkin Lymphoma, Adult,Hodgkin's Disease,Hodgkin's Lymphoma,Hodgkins Disease,Lymphocyte Depletion Hodgkin's Lymphoma,Lymphocyte-Rich Classical Hodgkin's Lymphoma,Mixed Cellularity Hodgkin's Lymphoma,Nodular Lymphocyte-Predominant Hodgkin's Lymphoma,Nodular Sclerosing Hodgkin's Lymphoma,Adult Hodgkin Lymphoma,Disease, Hodgkin,Disease, Hodgkin's,Disease, Hodgkins,Hodgkin Granuloma,Hodgkin's Granuloma,Hodgkins Granuloma,Hodgkins Lymphoma,Lymphocyte Rich Classical Hodgkin's Lymphoma,Lymphogranulomas, Malignant,Lymphoma, Hodgkin,Lymphoma, Hodgkin's,Malignant Granuloma,Malignant Granulomas,Malignant Lymphogranuloma,Malignant Lymphogranulomas,Nodular Lymphocyte Predominant Hodgkin's Lymphoma
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006834 Hydrazines Substituted derivatives of hydrazine (formula H2N-NH2). Hydrazide
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Y Kenis, and J Werli, and J Hildebrand, and H J Tagnon
[Treatment of lymphomas with a derivative of methylhydrazine (Ro 4-6467). Clinical study on 34 cases].
January 1967, Sangre,
Y Kenis, and J Werli, and J Hildebrand, and H J Tagnon
[A new methylhydrazine derivative (Ro 4-6467 or Natulan) in the treatment of Hodgkin's disease. Study of 10 cases].
July 1966, Revista brasileira de medicina,
Y Kenis, and J Werli, and J Hildebrand, and H J Tagnon
[ON CHEMOTHERAPY WITH THE METHYLHYDRAZINE DERIVATIVE RO-4-6467 IN HEMOBLASTOSES AND CARCINOMAS].
January 1964, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
Y Kenis, and J Werli, and J Hildebrand, and H J Tagnon
THE TUMOR-INHIBITORY EFFECTS OF THE METHYLHYDRAZINE DERIVATIVE RO 4-6467/1 (NSC-77213).
December 1963, Cancer chemotherapy reports,
Y Kenis, and J Werli, and J Hildebrand, and H J Tagnon
Histology of rat placentas treated with methylhydrazine Ro 4-6467.
January 1990, Boletin de estudios medicos y biologicos,
Y Kenis, and J Werli, and J Hildebrand, and H J Tagnon
[Initial results with a new cytostatic (Ro 4-6467) in 2 cases of Hodgkin's disease].
June 1967, Hospital (Rio de Janeiro, Brazil),
Y Kenis, and J Werli, and J Hildebrand, and H J Tagnon
Hodgkin's disease and other malignant lymphomas.
October 1970, California medicine,
Y Kenis, and J Werli, and J Hildebrand, and H J Tagnon
[Hodgkin's disease and other malignant lymphomas].
May 1972, Ugeskrift for laeger,
Y Kenis, and J Werli, and J Hildebrand, and H J Tagnon
A METHYLHYDRAZINE DERIVATIVE IN HODGKIN'S DISEASE AND OTHER MALIGNANT NEOPLASMS. THERAPEUTIC AND TOXIC EFFECTS STUDIED IN 51 PATIENTS.
July 1965, Annals of internal medicine,
Y Kenis, and J Werli, and J Hildebrand, and H J Tagnon
[Treatment of lymphomas with methyl-hydrazine (Ro 4-6467/1, MIH, "Natulanar")].
September 1966, Hospital (Rio de Janeiro, Brazil),
Copied contents to your clipboard!